Paliperidone palmitate vs placebo
Relapse: recurrence of psychotic symptoms Reported by trial author as adverse event · patients with schizophrenia
Paliperidone palmitate probably leads to lower relapse: recurrence of psychotic symptoms Reported by trial author… compared with placebo (moderate certainty).
1 finding from 1 review
- RR 0.56 [0.46, 0.7]5 studies · 2084 participantsModerate